This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 01 Feb 2022  |  Global

    Frost Radar™: Global Enterprise Health Cloud Infrastructure and Platform Services, 2021

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    The COVID-19 pandemic has revealed that many healthcare organizations have neither the agility and business continuity programs nor the technologies needed to support them during a crisis. Consequently, some have been forced to act on cloud and digital transformation strategies they had been delaying. The cloud has been critical in helping healthca...

    $4,950.00
  2. 31 Jan 2022  |  North America

    Global Digital Health Investments Growth Opportunities

    On-demand Healthcare Services and AI-enabled Care Delivery Enable Future Growth Potential

    Frost & Sullivan observed a significant increase in the digital transformation of healthcare and demand for effective IT solutions to improve care delivery, creating a lot of excitement among investors. Venture capitalist activities in health technology rise as healthcare organizations, clinical trial providers, insurance firms, employers, and poli...

    $2,450.00
  3. 31 Jan 2022  |  Asia Pacific

    Enterprise Imaging Partnerships and Growth Opportunities in Selected Asia-Pacific Countries

    New Business Models Overcome Budget Restrictions to Enable Equipment Purchase and Management

    In this report, Frost & Sullivan analyzes emerging business models in the medical imaging industry in Asia-Pacific, focusing on India, Australia, Vietnam, Indonesia, and Singapore. Conventional business models that focus on selling products based on specification superiority or unique selling propositions are forecast to slow down. Requirement chan...

    $2,450.00
  4. The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The issue includes novel catheter technologies, such as drug coated balloon, focused force coronary dilation catheter, and endovascular ultrasound guided endovenous valve forrmation sys...

    $950.00
  5. 28 Jan 2022  |  Global

    Global Cancer Survivorship Care Growth Opportunities

    Patient-reported Outcome (PRO) Tools and Electronic Health Record (EHR)-Integrated Solutions Specific to Cancer Survivorship Care Will Drive Market Growth

    The global cancer survivorship care market has gained significance due to improvements in cancer treatment and the rising cancer survival rates. The availability of reimbursement policies in the United States favors the cancer survivorship care market in the country. Several health IT companies are considering the use of electronic health records (...

    $2,450.00
  6. 24 Jan 2022  |  North America

    Global CT Equipment Procedure Volumes and Reimbursement Growth Opportunities

    Demand for Pulmonary and Abdomen-based Imaging Accelerating the Growth of CT Procedures

    An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing at 3% to 4% every year. While the COVID-19 pandemic in 2020 led to a drop in CT procedures by over 20%, the industry is expected to be completely functional by the end of 2021. Pandemic-based sanitization protocols and patient hesitancy remain restrain...

    $2,450.00
  7. This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on innovations that leverage artificial intelligence (AI) and machine learning (ML) algorithms for diagnostics and drug discovery applications. Innovations around AI and ML augmented diagnostics have been highlighted, which include molecular diagnostics,...

    $950.00
  8. 17 Jan 2022  |  Global

    Global Advances in Omics Technologies Enable Future Drug Discovery and Growth Opportunities

    Emerging Omics Platforms Drive Precision Drug Discovery

    For a long time, drug discovery followed the same path and used conventional analysis methods for proposed targets. Today, changes in technology and the ability to study omics are transforming drug development. Personalized therapy is on the rise and promises to be more effective and efficient in addressing challenges. With growing interest in ...

    $4,950.00
  9. 06 Jan 2022  |  Global

    Global Diabetes Devices and Services Growth Opportunities

    Growth Strategies in an Increasingly Competitive and Digitalized Environment

    The diabetes industry offers significant growth opportunities, given the rising prevalence of this disease condition. However, the devices space comprising self-monitoring of blood glucose (SMBG, or glucometer), continuous glucose monitors (CGMs), insulin pens, and insulin pumps are facing unprecedented threats and challenges, some of which are def...

    $2,450.00
  10. 03 Jan 2022  |  Global

    AI Augmentation in Molecular Diagnostics

    AI Applications to improve predictive, diagnostic, and prognostic value of molecular diagnostics

    This Frost & Sullivan research service discusses advances in AI integration in Molecular Diagnostics, highlights key advantages of incorporating AI in the diagnostics workflow and roadblocks that have prevented it from becoming mainstream. While AI is widely used in radiology- and pathology-based diagnostics, its adoption is gradually increasing in...

    $4,950.00